Safety Profile
Testosterone Cypionate
Updated today
Regulatory Status
Safety Summary
- Schedule III controlled substance
- cardiovascular risks
- polycythemia
- liver toxicity at high doses
- hormonal suppression
Testosterone Cypionate's 3/10 rating is in our caution tier. Either documented side-effect patterns are concerning, the human safety dataset is too thin to make confident statements, or the compound is under active regulatory scrutiny. We recommend reviewing the full notes above and consulting a licensed physician before any research use.
Methodology
How we rate peptide safety
Every compound in our index gets a 1–10 safety score based on four weighted factors. The score reflects known research-use risk — not medical advice.
- 40% — Clinical evidence. Volume of peer-reviewed trials, sample sizes, duration, and consistency of outcomes. FDA-approved compounds anchor the top end (8–10); preclinical-only compounds cap at 6.
- 30% — Adverse-event profile. Severity and frequency of reported side effects, including GI events, cardiovascular signals, hypoglycemia, and long-term organ effects.
- 20% — Regulatory status. FDA approval, EMA approval, or status in active clinical trials. Compounds under safety warnings are penalized.
- 10% — Community-reported outcomes. Reddit, forum, and published case-report signal beyond formal trials. Used as a late-stage tiebreaker, not a leading factor.
Related compounds
Other compounds researchers compare with Testosterone Cypionate
Safety ratings are derived from published clinical data, FDA approval status, and community-reported outcomes. They are not medical advice. Always consult a healthcare professional before using any research compound.
